Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease. The diagnosis is
made on the basis of McDonald's diagnostic criteria, which include clinical manifestations …

Background Patients with biopsy-proven systemic sarcoidosis who develop a chronic CNS
disorder are often presumed to have neurosarcoidosis (NS), however, the possibility of …

Neurosarcoidosis is an important diagnosis to exclude in the work-up for suspected multiple
sclerosis (MS). The distinction between the two conditions is usually possible due to …

OBJECTIVE: To compare the incidence of multiple sclerosis (MS) and neurosarcoidosis
(NS) diagnoses among patients with systemic sarcoidosis and subsequent neurologic …

Sarcoidosis is a multisystem inflammatory disease of unknown etiology that predominantly
affects the lungs and intrathoracic lymph nodes, but in 6% of cases it also occurs in central …

Neurologic presentations complicate the course of sarcoidosis in approximately 5% to 26%
of patients. 1–3 A neurologic illness suggestive of neurosarcoidosis (NS) can develop in a …

Objective To characterize the clinical and laboratory features of neurosarcoidosis (NS),
presenting with findings consistent with multiple sclerosis (MS). Methods Retrospective chart …

Sir, Sarcoidosis is a granulomatous disease involving mainly the most common lymph
nodes, the mediastinal ones, followed by lungs, skin, and eyes. Involvement of the nervous …

Sarcoidosis is an inflammatory multisystem disorder of unknown cause. Practically no organ
is immune to sarcoidosis; most commonly, in up to 90% of patients, it affects the lungs. The …

3. Discussion Neurosarcoidosis is known to be a rare, usually severe, manifestation of
sarcoidosis. Corticosteroids are used since nearly 60 years successfully in sarcoidosis and …